glp-1 digital health platforms startups 5 Looking to Compete in the Obesity Space AI Meets GLP-1: Helping Pharma

In the future, the following points are worthy of attention

*Disclaimer: Major Players sorted in no particular order Recent Industry Developments June 2022: Gulf Pharmaceutical Industries (Julphar) and Hangzhou Zhongmei Huadong Pharmaceutical Co

The LEADER trial for liraglutide 1.8 mg demonstrated cardiovascular benefits in high-risk populations with type 2 diabetes

Bibcode:2017JMolE..85..205H

And while she may be a backyard breeder of a lengthy royal line of inbred corgis, the photo above attests that she also loves cavalier King Charles spaniels

The compound faces bioavailability challenges, and some users report that effects vary significantly between batches, possibly due to stability issues